For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn something new every day.

Forget college essays. Artificial intelligence has much bigger fish to fry.

Biotech firm Insilico Medicine said Monday that it entered an "AI-discovered-and-designed" drug into Phase 2 clinical trials involving human subjects, a first for the industry. The robots: they may not be so bad after all.

Continue reading

Source Fool.com